Website intended for a NZ health professional readership
The New Zealand Medical Journal's 4 June 2021 issue is out now.
EDITORIAL: “We have been warned”— preparing now to prevent the next pandemic
4918. Ciguatera poisoning and confirmation of ciguatoxins in fish imported into New Zealand
4987. What helps and hinders metformin adherence and persistence: a qualitative study exploring the views of people with type 2 diabetes
5010. The emergence of azole resistance in Aspergillus fumigatus complex in New Zealand
5011. Improving the prescribing practice of junior doctors through interprofessional collaboration and evidence-based education
5076. Primary medication non-adherence to analgesics and antibiotics at Counties Manukau Health Emergency Department
5114. Complications of endoscopically placed duodenal stents for malignant duodenal outlet obstruction
5149. Patch testing to plants: sensitisation associated with exposure to plants, essential oils and botanicals in cosmetics
5035. VIEWPOINT: Participant injury in clinical trials conducted in New Zealand for the benefit of manufacturers: an unfair system?
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
